Sol-Gel Technologies Ltd. (SLGL)
NASDAQ
$67.14+$6.40 (+10.54%) on the dayAs of the close; data may be delayed.
SLGL price, last 12 months
Key stats
- Previous close
- $60.74
- Open
- $61.25
- Day range
- $61.05 – $67.29
- 52-week range
- $27.00 – $97.97
- Volume
- 18.5K
- Avg volume (20 days)
- 63.4K
- Market cap
- $218.9M
Performance
1W+11.9%
1M−15.5%
3M−8.7%
6M−13.7%
YTD+59.3%
1Y+141.5%
vs S&P 500, 1Y+124.7 pts
Technicals and fundamentals
About Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
- Listed on
- NASDAQ
- Market cap
- $218.9M